PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS

Overview Fund Activity
Delisted

PHAS was delisted on the 2nd of November, 2022.

Back to rankings

19 hedge funds and large institutions have $65.8M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
19
Holders Change
+4
Holders Change %
+26.67%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RSCM
1
Rock Springs Capital Management
Maryland
$10.8M
2
EI
2
EAM Investors
California
$898K
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$725K
4
SSA
4
Schonfeld Strategic Advisors
New York
$600K
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$32.6M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$7.99M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$0
3
Citigroup
3
Citigroup
New York
$0
4
DCM
4
DAFNA Capital Management
California
$689K
5
LCM
5
Laurion Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$32.6M 3,429,779 +58,819 +2%
RSCM
2
Rock Springs Capital Management
Maryland
$10.8M 1,140,000 +305,000 +37%
CAM
3
Cormorant Asset Management
Massachusetts
$7.99M 839,642 -258,284 -24%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$6.2M 651,701 +600 +0.1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.75M 183,994 +8,000 +5%
Millennium Management
6
Millennium Management
New York
$1.16M 121,979 -11,043 -8%
EI
7
EAM Investors
California
$898K 94,382 +94,382 New
USAA
8
United Services Automobile Association
Texas
$881K 92,614 – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$725K 76,304 +76,304 New
DCM
10
DAFNA Capital Management
California
$689K 72,500 -27,500 -28%
SSA
11
Schonfeld Strategic Advisors
New York
$600K 63,000 +63,000 New
BlackRock
12
BlackRock
New York
$430K 45,261 +19,952 +79%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$407K 42,845 +42,845 New
TD Asset Management
14
TD Asset Management
Ontario, Canada
$302K 31,788 +600 +2%
TEE
15
Tibra Equities Europe
United Kingdom
$217K 22,778 +22,778 New
Barclays
16
Barclays
United Kingdom
$60K 6,300 +6,300 New
Bank of America
17
Bank of America
North Carolina
$37K 3,850 +3,850 New
Morgan Stanley
18
Morgan Stanley
New York
$21K 2,231 +2,231 New
UBS Group
19
UBS Group
Switzerland
$17K 1,745 +1,745 New
Alyeska Investment Group
20
Alyeska Investment Group
Illinois
– – -191,602 Closed
Citigroup
21
Citigroup
New York
– – -113,605 Closed
LCM
22
Laurion Capital Management
New York
– – -54,072 Closed
Deutsche Bank
23
Deutsche Bank
Germany
– – -2,136 Closed
TRCT
24
Tower Research Capital (TRC)
New York
– – -408 Closed
CFGS
25
Concourse Financial Group Securities
Alabama
– – – –